These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30953495)

  • 1. Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study.
    Oetzel JG; Lao C; Morley M; Penman K; Child M; Scott N; Karalus M
    BMC Public Health; 2019 Apr; 19(1):385. PubMed ID: 30953495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study.
    Barker H; Oetzel JG; Scott N; Morley M; Carr PEA; Oetzel KB
    Int J Equity Health; 2017 Nov; 16(1):201. PubMed ID: 29149897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatches between health service delivery and community expectations in the provision of secondary prophylaxis for rheumatic fever in New Zealand.
    Anderson A; Peat B; Ryland J; Ofanoa M; Burgess H; Malungahu G; Wade J; Spray J; Leversha A
    Aust N Z J Public Health; 2019 Jun; 43(3):294-299. PubMed ID: 30908804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatic fever in New Zealand.
    Webb R; Wilson N
    J Paediatr Child Health; 2013 Mar; 49(3):179-84. PubMed ID: 22050578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.
    Gasse B; Baroux N; Rouchon B; Meunier JM; Frémicourt ID; D'Ortenzio E
    BMC Public Health; 2013 Feb; 13():131. PubMed ID: 23402561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low adherence to secondary prophylaxis among clients diagnosed with rheumatic fever, Jamaica.
    Thompson SB; Brown CH; Edwards AM; Lindo JL
    Pathog Glob Health; 2014 Jul; 108(5):229-34. PubMed ID: 25113585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute rheumatic fever: adherence to secondary prophylaxis and follow up of Indigenous patients in the Katherine region of the Northern Territory.
    Stewart T; McDonald R; Currie B
    Aust J Rural Health; 2007 Aug; 15(4):234-40. PubMed ID: 17617086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.
    de Dassel JL; de Klerk N; Carapetis JR; Ralph AP
    J Am Heart Assoc; 2018 Dec; 7(24):e010223. PubMed ID: 30561268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinic factors associated with better delivery of secondary prophylaxis in acute rheumatic fever management.
    Quinn E; Girgis S; Van Buskirk J; Matthews V; Ward JE
    Aust J Gen Pract; 2019 Dec; 48(12):859-865. PubMed ID: 31774991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.
    Ralph AP; de Dassel JL; Kirby A; Read C; Mitchell AG; Maguire GP; Currie BJ; Bailie RS; Johnston V; Carapetis JR
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatic heart disease in indigenous populations--New Zealand experience.
    Wilson N
    Heart Lung Circ; 2010; 19(5-6):282-8. PubMed ID: 20395173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management and patient persistence with antibiotic course in suspected group A streptococcal pharyngitis for primary prevention of rheumatic fever: the perspective from a New Zealand emergency department.
    Mathan JJ; Ekart J; Houlding A; Payinda G; Mills C
    N Z Med J; 2017 Jun; 130(1457):58-68. PubMed ID: 28617790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic heart disease in indigenous populations.
    White H; Walsh W; Brown A; Riddell T; Tonkin A; Jeremy R; Brieger D; Zeitz C; Kritharides L
    Heart Lung Circ; 2010; 19(5-6):273-81. PubMed ID: 20356783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatic fever - identification, management and secondary prevention.
    Smith MT; Zurynski Y; Lester-Smith D; Elliott E; Carapetis J
    Aust Fam Physician; 2012; 41(1-2):31-5. PubMed ID: 22276281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-designing an intervention to prevent rheumatic fever in Pacific People in South Auckland: a study protocol.
    Tu'akoi S; Ofanoa M; Ofanoa S; Lutui H; Heather M; Jansen RM; van der Werf B; Goodyear-Smith F
    Int J Equity Health; 2022 Jul; 21(1):101. PubMed ID: 35864550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of acute rheumatic fever in New Zealand 1996-2005.
    Jaine R; Baker M; Venugopal K
    J Paediatr Child Health; 2008 Oct; 44(10):564-71. PubMed ID: 19012628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
    Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
    BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons to be learned: Using National Immunisation strategies to improve adherence to acute rheumatic fever secondary prophylaxis.
    Liaw JY; White AV; Gorton S; Axford-Haines L
    J Paediatr Child Health; 2019 Oct; 55(10):1170-1176. PubMed ID: 31410921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
    Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
    Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.